TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/19 16:04 | 8/30/19 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Broom Colin Md | PA | D | P | 21 | 2.03 | 0 | 10 | 5 | 209 | D | |||||||||||||||
6/25/18 09:47 | 6/22/18 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Broom Colin Md | PA | DO | CEO,Dir | P | 19 | 3.72 | 0 | 5 | 3 | 175 | D | ||||||||||||||
5/23/18 20:36 | 5/23/18 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Broom Colin Md | PA | DO | CEO,Dir | P | 46 | 4.60 | 0 | 10 | 6 | 170 | D | ||||||||||||||
9/26/17 17:01 | 9/22/17 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Broom Colin Md | PA | DO | CEO | P | 22 | 8.35 | 0 | 3 | 2 | 160 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |